Millennium-affiliated holders disclose 271,456 shares in Unicycive Therapeutics (UNCY)

Rhea-AI Filing Summary

Unicycive Therapeutics, Inc. amendment to a Schedule 13G/A reports shared beneficial ownership stakes held by Millennium-related entities and Integrated Core Strategies (US) LLC. Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each report 271,456 shares (1.0%). Integrated Core Strategies (US) LLC reports 205,529 shares (0.8%). The filing includes a Joint Filing Agreement dated July 7, 2026 and discloses that the holdings are held by entities subject to voting and investment control by Millennium-affiliated managers.

Insights

Governance Counsel

Schedules clarify shared investment control across Millennium entities and an affiliated holder.

The amendment lists shared dispositive and voting power for 271,456 shares by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, and 205,529 shares by Integrated Core Strategies (US) LLC as of the cover information. The filing cites a July 7, 2026 Joint Filing Agreement signed by the parties.

The filing emphasizes agency and control relationships: securities are held by entities over which Millennium-related managers have voting or investment discretion. Subsequent disclosures in periodic filings would be the appropriate place to observe any changes to these holdings.

Key Figures

Millennium-held shares: 271,456 shares Millennium percent: 1.0% Integrated Core shares: 205,529 shares +3 more

6 metrics

Millennium-held shares 271,456 shares reported by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander

Millennium percent 1.0% percent of class reported alongside 271,456 shares

Integrated Core shares 205,529 shares reported by Integrated Core Strategies (US) LLC

Integrated Core percent 0.8% percent of class reported alongside 205,529 shares

CUSIP 90466Y202 Unicycive Therapeutics common stock CUSIP as listed on cover

Joint Filing Agreement date July 7, 2026 Exhibit I: Joint Filing Agreement among reporting parties

Key Terms

Schedule 13G/A, beneficial ownership, shared dispositive power, Joint Filing Agreement

4 terms

Schedule 13G/A regulatory

"amendment to a Schedule 13G/A reports shared beneficial ownership stakes"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficial ownership financial

"Amount beneficially owned: See response to Item 9 on each cover page"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

shared dispositive power financial

"Shared Dispositive Power 271,456.00"

Joint Filing Agreement legal

"Exhibit I: Joint Filing Agreement, dated as of July 7, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/08/2026 - 05:51 PM Accepted by SEC EDGAR 07/08/2026 - 05:51 PM Learn about SEC filing dates

FAQ

What stake does Millennium Management report in UNCY?

Millennium Management LLC reports 271,456 shares (1.0%). The filing shows shared voting and dispositive power over those shares and states the holdings are held by entities subject to Millennium-related voting or investment control.

How many shares does Integrated Core Strategies (US) LLC report for UNCY?

Integrated Core Strategies (US) LLC reports 205,529 shares (0.8%). The cover responses list shared voting and shared dispositive power for that amount and include a Joint Filing Agreement dated July 7, 2026.

Does Israel A. Englander personally own the reported UNCY shares?

The filing attributes 271,456 shares (1.0%) to entities linked to Israel A. Englander with shared control; it states this should not be construed as an admission of personal beneficial ownership by Mr. Englander.

What document binds the reporting parties together?

The parties executed a Joint Filing Agreement dated July 7, 2026. The agreement is cited as Exhibit I and governs the joint filing among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander.

What is the CUSIP for Unicycive Therapeutics common stock?

The reported CUSIP for the common stock class is 90466Y202. The filing lists the class as Common Stock with par value $0.001 per share and includes issuer address details.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Unicycive Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

90466Y202

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 90466Y202

1

Names of Reporting Persons

Integrated Core Strategies (US) LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 205,529.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 205,529.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

205,529.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.8 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 90466Y202

1

Names of Reporting Persons

Millennium Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 271,456.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 271,456.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

271,456.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 90466Y202

1

Names of Reporting Persons

Millennium Group Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 271,456.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 271,456.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

271,456.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 90466Y202

1

Names of Reporting Persons

Israel A. Englander

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 271,456.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 271,456.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

271,456.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Unicycive Therapeutics, Inc.
(b)	Address of issuer's principal executive offices: 1975 W. El Camino Real, Suite 204, Mountain View, California 94040
Item 2.
(a)	Name of person filing: Integrated Core Strategies (US) LLC Millennium Management LLC Millennium Group Management LLC Israel A. Englander
(b)	Address or principal business office or, if none, residence: Integrated Core Strategies (US) LLC c/o Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
(c)	Citizenship: Integrated Core Strategies (US) LLC - Delaware Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 90466Y202
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Integrated Core Strategies (US) LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/07/2026

Millennium Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/07/2026

Millennium Group Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/07/2026

Israel A. Englander

Signature:	/s/ Israel A. Englander
Name/Title:	Israel A. Englander
Date:	07/07/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner

Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of July 7, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.